- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00315978
The Impact of Patient Involvement in Decision-Making About Heart Disease Prevention
Decision Aid to Improve Coronary Heart Disease Risk Modification: a Pilot Randomized Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: Low utilization of effective CHD prevention strategies may be due to many factors, but chief among them is the lack of patient involvement in prevention decisions. We undertook this study to test the effectiveness of an individually-tailored, computerized decision aid about CHD on patients' discussions with their doctor and their plans for CHD prevention.
Methods: We conducted a pilot randomized trial in a convenience sample of adults with no previous history of cardiovascular disease to test the effectiveness of an individually-tailored, computerized decision aid about CHD prevention against a risk factor list that patients could present to their doctor.
Study Type
Enrollment
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599
- University of North Carolina at Chapel Hill
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- presenting for routine medical care with regular medical provider
- able to understand, speak, and read English
Exclusion Criteria:
- prior history of cardiovascular disease
- history of serious medical illness that would limit candidacy for screening
- previous participation in intensive risk modification as part of diabetes study in our clinic
- no cholesterol measurement in the last 3 years, limiting ability to provide up-to-date risk estimate
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
Discussion with provider about CHD risk reduction
|
|
Stated plans for CHD risk reduction
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
Knowledge about CHD prevention
|
|
Perception of CHD risk
|
|
Interest in participating in decision-making
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Stacey L. Sheridan, MD, MPH, University of North Carolina, Chapel Hill
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Completion
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 03-MED-221
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.